Naturopathix and ZymaDerm™ in the NEWSDr. Briant Burke and Naturopathix in the news. ZymaDerm news releases and other significant events in the company's timeline.
In 2010, FOX News, KTRV Channel 12, featured Dr. Briant Burke, Naturopathix and ZymaDerm™ “New breakthrough treatment for molluscum™. This was after Walgreens selected ZymaDerm™ for its stores, a momentous point in the company’s history.
September 1, 2015
Naturopathix, Inc. announces a $10 mail-in rebate for in-store Walgreens purchases of ZymaDerm™, the most widely used, gentle and effective treatment for molluscum contagiosum, a common childhood viral skin disease of highly contagious, unsightly warty lesions that can cover extensive areas of the body and infects almost 2.5 million children in the USA.
July 7, 2014
Summer is the prime time for molluscum contagiosum, a highly contagious viral skin condition that is on the rise and infects over a million children in the USA each year according to Naturopathix’s Briant Burke, MD, MS, whose ZymaDerm™ has effectively treated over half a million patients, offers tips on how to avoid, recognize, treat and not spread the molluscum infection to others.
May 30, 2014
Naturopathix, Inc. appoints Taiwan’s Teh Yuh Trading Company as its Asia distributor for ZymaDerm™ the United States most widely used painless, safe and inexpensive natural topical treatment for molluscum contagiosum. The distribution agreement grew out of an Asia Trade Mission organized by Idaho Governor “Butch” Otter and attended by Naturopathix founder Brian Burke, MD, MS.
May 22, 2014
Naturopathix, Inc. has introduced ZymaDerm™ the all-natural choice for fast, powerful relief from cold sore misery comprised of a unique blend of soothing essential oils and organically bound trace minerals to rapidly dry out and help heal cold sores and fever blisters.
April 30, 2014
Zymaderm™, the most widely used painless and inexpensive natural topical treatment for molluscum contagiosum In the United States, has filed for a CE Mark to market and sell throughout the European Economic Area.
CVS, the largest health care provider in the U.S., has selected ZymaDerm™, the most widely used painless topical treatment for molluscum contagiosum, for sale at its local drugstores. Now it’s never been easier to make this embarrassing skin condition painlessly vanish.
Idaho Governor “Butch” Otter has invited Naturopathix,Inc., maker of all-natural patented ZymaDerm™ for molluscum, to participate in the Governor’s trade mission to Asia in April 2013. Meetings with distributors and retailers in Korea and Taiwan are anticipated to bring the painless treatment for molluscum developed by Briant Burke, MD, MS to these countries and open the door for distribution throughout Asia.
In an independent study of 346 physicians that used samples of ZymaDerm™, a natural non-toxic topical treatment for their patients with molluscum contagiosum, 92% of those responding rated it as effective, while 86% stated that they were either likely or extremely likely to use ZymaDerm™ as their preferred treatment method for molluscum contagiosum, compared to prescription drugs, over-the-counter treatment options, or physical destruction of lesions.
Scientific proof for the effectiveness of Zymaderm™ in the treatment of molluscum contagiosum was announced today by Naturopathix,Inc., with the publication of a randomized controlled clinical trial demonstrating that the combination of tea tree oil and organically bound iodine found in ZymaDerm™ is effective in reducing or eliminating molluscum lesions in over 85% of children in 30 days. The study was published in the March issue of the prestigious Journal of Drugs in Dermatology and conducted by the Center for Biomedical Research,Inc.
Naturopathix,Inc. announced today that North Carolina Mutual Drug Distribution has selected ZymaDerm™, a painless, safe, effective, patented treatment of molluscum contagiosum, for distribution to leading pharmacies in the South East. It joins distributors Smith Drug and drugstore chains Walgreens’s and Pharmaca Integrative Pharmacies that sell ZymaDerm™ in its stores, as well as leading online merchants that include Drugstore.com and Amazon.com.
Naturopathix announces that Cardinal Health selects ZymaDerm™ for its painless, safe and effective treatment of molluscum contagiosum for distribution to leading pharmacies nationwide. It joins distributors Smith Drug and drugstore chains that include Walgreens’s and Pharmaca Integrative Pharmacies that sell ZymaDerm™ in its stores, as well as leading online merchants that include Drugstore.com and Amazon.com.
Walgreen’s, the nation’s largest drugstore chain, has selected ZymaDerm™, the most widely used painless topical treatment for molluscum contagiosum, for sale at it’s local drugstores nationwide. Now it’s never been easier to make this embarrassing skin condition painlessly vanish in 30 days.
Naturopathix, Inc. has been awarded US Patent #7,311,928 for its unique painless treatment for molluscum contagiosum, Dr. Briant Burke, MD announced today. Molluscum contagiosum is a skin malady common in children and found increasingly in adults. The product, ZymaDerm, is a plant based topical solution with unique skin penetrating abilities so it may be applied directly onto the intact molluscum bump, with no burning, painful squeezing, pin pricking or scraping required.
Dr. Briant Burke, MD, developer of the patented, over-the-counter topical treatment for molluscum contagiosum called ZymaDerm, announced today that the Center for Biomedical Research, Inc. has launched a commercial spin off for e-commerce named Naturopathix, Inc.